NASDAQ: FTEK

FUEL TECH, INC.

CIK 0000846913 · SIC 3564 · Industrial & Commercial Fans & Blowers & Air Purifing Equip

Micro Revenue $27M Assets $43M as of Nov 1, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (FLEX 10-Q) is open in full — no account needed.

8-K Filed Nov 3, 2026 · Period ending Nov 3, 2026

Summary not yet generated.

10-Q Filed Nov 3, 2026 · Period ending Sep 30, 2026

Summary not yet generated.

Partner

Trade FTEK commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Sep 18, 2026 · Period ending Sep 14, 2026

Summary not yet generated.

8-K Filed Sep 2, 2026 · Period ending Aug 27, 2026

Summary not yet generated.

8-K Filed Aug 4, 2026 · Period ending Aug 4, 2026

Summary not yet generated.

8-K Filed Aug 4, 2026 · Period ending Jul 31, 2026

Summary not yet generated.

10-Q Filed Aug 4, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

10-Q Filed May 5, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

10-K Filed Mar 3, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-K Filed Mar 4, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

424B3 Filed Apr 1, 2021

Summary not yet generated.

10-K/A Filed Apr 1, 2013 · Period ending Dec 31, 2012

Summary not yet generated.

10-Q/A Filed Jan 7, 2005 · Period ending Jun 30, 2004

Summary not yet generated.

Latest financial statements

From 10-Q filed Nov 3, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations (Unaudited)

(in thousands, except share and per-share data)

Description Three months ended September 30, 2026 Three months ended September 30, 2025 Nine months ended September 30, 2026 Nine months ended September 30, 2025
Revenues 8,676 7,490 21,241 19,430
Costs and expenses:
Cost of sales 4,771 3,829 12,017 10,281
Selling, general and administrative 3,657 3,207 10,967 9,895
Research and development 771 450 1,941 1,510
9,199 7,486 24,925 21,686
Operating (loss) income (523) 4 (3,684) (2,256)
Interest income 247 311 753 1,127
Other income (expense), net 9 (5) 88 15
(Loss) income before income taxes (267) 310 (2,843) (1,114)
Income tax expense — (7) (9) (11)
Net (loss) income (267) 303 (2,852) (1,125)
Net (loss) income per common share:
Basic net (loss) income per common share (0.01) 0.01 (0.09) (0.04)
Diluted net (loss) income per common share (0.01) 0.01 (0.09) (0.04)
Weighted-average number of common shares outstanding:
Basic 31,217,000 31,074,000 31,164,000 30,890,000
Diluted 31,217,000 31,293,000 31,164,000 30,890,000

Condensed Consolidated Balance Sheets (Unaudited)

(in thousands, except share and per-share data)

Description September 30, 2026 December 31, 2025
ASSETS
Current assets:
Cash and cash equivalents 6,830 11,939
Short-term investments 11,000 12,942
Accounts receivable, less current expected credit loss of $107 and $108, respectively 5,891 5,355
Inventories, net 382 373
Prepaid expenses and other current assets 899 1,335
Total current assets 25,002 31,944
Property and equipment, net of accumulated depreciation of $17,748 and $19,433, respectively 4,688 4,739
Goodwill 2,116 2,116
Other intangible assets, net of accumulated amortization of $622 and $561, respectively 587 646
Right-of-use operating lease assets, net 480 536
Long-term investments 9,950 6,991
Other assets 208 207
Total assets 43,031 47,179
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable 3,009 3,242
Accrued liabilities:
Operating lease liabilities current 101 89
Employee compensation 744 1,308
Other accrued liabilities 1,124 1,634
Total current liabilities 4,978 6,273
Operating lease liabilities non-current 421 491
Deferred income taxes, net 187 187
Other liabilities 294 296
Total liabilities 5,880 7,247
Stockholders’ equity:
Common stock, $.01 par value, 40,000,000 shares authorized, 32,457,627 and 32,281,179 shares issued, and 31,216,789 and 31,074,438 shares outstanding, respectively 324 322
Additional paid-in capital 165,775 165,616
Accumulated deficit (124,648) (121,796)
Accumulated other comprehensive loss (1,763) (1,718)
Nil coupon perpetual loan notes 76 76
Treasury stock, at cost (2,613) (2,568)
Total stockholders’ equity 37,151 39,932
Total liabilities and stockholders’ equity 43,031 47,179

Condensed Consolidated Statements of Cash Flows (Unaudited)

(in thousands)

Description Nine months ended September 30, 2026 Nine months ended September 30, 2025
Operating Activities
Net loss (2,852) (1,125)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation 537 490
Amortization 62 27
Loss on disposal of equipment 15 —
Interest income on held-to-maturity securities, net of premium amortization and discount accretion 81 (91)
Provision for credit losses, net of recoveries (1) —
Stock-based compensation, net of forfeitures 161 269
Changes in operating assets and liabilities:
Accounts receivable (556) 3,066
Employee retention credit receivable — 1,677
Inventory (9) (4)
Prepaid expenses, other current assets and other non-current assets 429 318
Accounts payable (226) (560)
Accrued liabilities and other non-current liabilities (1,051) 516
Net cash (used in) provided by operating activities (3,410) 4,583
Investing Activities
Purchases of equipment and patents (505) (231)
Purchases of debt securities (12,102) (10,004)
Maturities of debt securities 11,000 11,000
Net cash (used in) provided by investing activities (1,607) 765
Financing Activities
Taxes paid on behalf of equity award participants (45) (222)
Net cash used in financing activities (45) (222)
Effect of exchange rate fluctuations on cash (47) 41
Net (decrease) increase in cash and cash equivalents (5,109) 5,167
Cash and cash equivalents at beginning of period 11,939 8,510
Cash and cash equivalents at end of period 6,830 13,677

Amounts as printed on the EDGAR/iXBRL face — (in thousands, except share and per-share data); (in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗